JP6050337B2 - プロテオミクスに基づく、慢性副鼻腔炎の診断用検出方法 - Google Patents

プロテオミクスに基づく、慢性副鼻腔炎の診断用検出方法 Download PDF

Info

Publication number
JP6050337B2
JP6050337B2 JP2014514556A JP2014514556A JP6050337B2 JP 6050337 B2 JP6050337 B2 JP 6050337B2 JP 2014514556 A JP2014514556 A JP 2014514556A JP 2014514556 A JP2014514556 A JP 2014514556A JP 6050337 B2 JP6050337 B2 JP 6050337B2
Authority
JP
Japan
Prior art keywords
subject
respiratory tract
upper respiratory
nthi
omp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2014514556A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014523525A (ja
JP2014523525A5 (https=
Inventor
スビノイ ダス,
スビノイ ダス,
ローレン オー. バカレッツ,
ローレン オー. バカレッツ,
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ohio State University
Original Assignee
Ohio State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ohio State University filed Critical Ohio State University
Publication of JP2014523525A publication Critical patent/JP2014523525A/ja
Publication of JP2014523525A5 publication Critical patent/JP2014523525A5/ja
Application granted granted Critical
Publication of JP6050337B2 publication Critical patent/JP6050337B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
    • A61B10/0045Devices for taking samples of body liquids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/285Assays involving biological materials from specific organisms or of a specific nature from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/12Pulmonary diseases
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/14Disorders of ear, nose or throat

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Surgery (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
JP2014514556A 2011-06-06 2012-06-05 プロテオミクスに基づく、慢性副鼻腔炎の診断用検出方法 Active JP6050337B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161493829P 2011-06-06 2011-06-06
US61/493,829 2011-06-06
PCT/US2012/040910 WO2012170422A1 (en) 2011-06-06 2012-06-05 Proteomics based diagnostic detection method for chronic sinusitis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016160374A Division JP2016194532A (ja) 2011-06-06 2016-08-18 プロテオミクスに基づく、慢性副鼻腔炎の診断用検出方法

Publications (3)

Publication Number Publication Date
JP2014523525A JP2014523525A (ja) 2014-09-11
JP2014523525A5 JP2014523525A5 (https=) 2015-07-23
JP6050337B2 true JP6050337B2 (ja) 2016-12-21

Family

ID=46208851

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014514556A Active JP6050337B2 (ja) 2011-06-06 2012-06-05 プロテオミクスに基づく、慢性副鼻腔炎の診断用検出方法
JP2016160374A Pending JP2016194532A (ja) 2011-06-06 2016-08-18 プロテオミクスに基づく、慢性副鼻腔炎の診断用検出方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016160374A Pending JP2016194532A (ja) 2011-06-06 2016-08-18 プロテオミクスに基づく、慢性副鼻腔炎の診断用検出方法

Country Status (9)

Country Link
US (4) US9568472B2 (https=)
EP (1) EP2718722B1 (https=)
JP (2) JP6050337B2 (https=)
AU (1) AU2012268380C1 (https=)
CA (1) CA2838488C (https=)
DK (1) DK2718722T3 (https=)
ES (1) ES2649370T3 (https=)
PL (1) PL2718722T3 (https=)
WO (1) WO2012170422A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014516028A (ja) * 2011-05-11 2014-07-07 リースベック ヘルスケア スウェーデン アクティエボラーグ ラミニン及びビトロネクチン結合特性を有するタンパク質f−新規インフルエンザ菌付着因子
PL2718722T3 (pl) * 2011-06-06 2018-04-30 Nationwide Children's Hospital, Inc. Oparty na proteomice diagnostyczny sposób wykrywania przewlekłego zapalenia zatok
US9279815B2 (en) * 2012-02-01 2016-03-08 Oklahoma Medical Research Foundation Human Streptococcus pneumoniae antibodies and uses therefor
RU2016109125A (ru) * 2013-08-16 2017-09-22 Огайо Стейт Инновейшн Фаундейшн Композиции и способы модуляции метилирования днк
US10921320B2 (en) 2015-03-30 2021-02-16 Entvantage Diagnostics, Inc. Devices and methods for diagnosis of sinusitis
US11650213B2 (en) 2015-03-30 2023-05-16 Entvantage Diagnostics, Inc. Devices and assays for diagnosis of viral and bacterial infections
US9606118B2 (en) * 2015-03-30 2017-03-28 Entvantage Diagnostics, Inc. Devices and assays for diagnosis of sinusitis
WO2018183421A1 (en) 2017-03-28 2018-10-04 Entvantage Diagnostics, Inc. Devices and methods for diagnosis of sinusitis

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0664065B2 (ja) * 1985-12-23 1994-08-22 日水製薬株式会社 菌体外膜保有菌の免疫学的測定法
US5763262A (en) 1986-09-18 1998-06-09 Quidel Corporation Immunodiagnostic device
KR910014706A (ko) 1990-01-10 1991-08-31 원본미기재 세척이 필요없는 개량된 이뮤노어세이(immunoassay)장치
US20020164354A1 (en) * 1998-09-30 2002-11-07 Barenkamp Stephen J. High molecular weight surface proteins of non-typeable haemphilus
US5415994A (en) 1993-08-02 1995-05-16 Quidel Corporation Lateral flow medical diagnostic assay device with sample extraction means
JP4850061B2 (ja) * 2004-03-18 2012-01-11 日水製薬株式会社 抗原の分析装置の製造方法及び分析装置
US20110294143A1 (en) * 2009-01-07 2011-12-01 Otsuka Pharmaceutical Co., Ltd. Method for detecting all haemophilus influenzae
WO2010092176A2 (en) * 2009-02-13 2010-08-19 Intercell Ag Nontypable haemophilus influenzae antigens
US20120276145A1 (en) * 2011-03-28 2012-11-01 House Research Institute Extracellular matrix proteins from haemophilus influenzae biofilms: targets for therapeutic or diagnostic use
PL2718722T3 (pl) * 2011-06-06 2018-04-30 Nationwide Children's Hospital, Inc. Oparty na proteomice diagnostyczny sposób wykrywania przewlekłego zapalenia zatok

Also Published As

Publication number Publication date
PL2718722T3 (pl) 2018-04-30
CA2838488C (en) 2020-06-30
EP2718722A1 (en) 2014-04-16
EP2718722B1 (en) 2017-10-18
AU2012268380A1 (en) 2014-01-16
WO2012170422A1 (en) 2012-12-13
DK2718722T3 (en) 2018-01-15
US10725040B2 (en) 2020-07-28
JP2016194532A (ja) 2016-11-17
JP2014523525A (ja) 2014-09-11
ES2649370T3 (es) 2018-01-11
US10048261B2 (en) 2018-08-14
US20140314876A1 (en) 2014-10-23
CA2838488A1 (en) 2012-12-13
US20190324037A1 (en) 2019-10-24
AU2012268380B2 (en) 2017-01-05
US20190004046A1 (en) 2019-01-03
US20170184589A1 (en) 2017-06-29
US9568472B2 (en) 2017-02-14
AU2012268380C1 (en) 2017-03-23
US10345300B2 (en) 2019-07-09

Similar Documents

Publication Publication Date Title
US10725040B2 (en) Proteomics based diagnostic detection method for chronic sinusitis
ES2976232T3 (es) Métodos y dispositivos mejorados para un diagnóstico exacto de infecciones
JP2014506244A5 (https=)
Wu et al. Diagnostic value of quantitative MP-IgG for Mycoplasma pneumoniae pneumonia in adults
CA3250869A1 (en) METHODS FOR EVALUATING THE PROBABILITY OF POST-OPERATIVE DELIRIUM IN PATIENTS UNDERGOING SURGERY
Liu et al. Clinical significance of serum S100A12 in acute otitis media in young children
CN107356757B (zh) 一种口腔鳞癌早期诊断试剂、试剂盒、检测方法及应用
TWI522367B (zh) Urine biomarkers are used to predict bladder and kidney cancer
EP3137908A2 (en) Methods and compositions for diagnosis and treatment of meningitis
KR102515934B1 (ko) 비감염성 폐질환 진단을 위한 바이오마커로서 cd20의 용도
WO2005114196A1 (ja) 間質性膀胱炎の検査方法
Jeong et al. Performance comparison between Elecsys anti-SARS-CoV-2 and anti-SARS-CoV-2 S and Atellica IM SARS-CoV-2 total and SARS-CoV-2 IgG assays
US9678084B2 (en) Compositions and methods related to S100A12
CN113366012A (zh) 幽门螺杆菌菌株的鉴定方法及鉴定试剂盒
Zhou et al. Plasma exosomes reveal insights into bovine tuberculosis pathogenesis and diagnostic opportunities
Tirone et al. Correlation of levels of α–defensins determined by HPLC-ESI-MS in bronchoalveolar lavage fluid with the diagnosis of pneumonia in premature neonates
US9261504B1 (en) Method and kit for detection of hemolytic uremic syndrome and necrotizing pneumonia in children with pneumococcal disease using serum fetuin-A levels as a biomarker
Mutavhatsindi et al. Identification of novel salivary candidate protein biomarkers for tuberculosis diagnosis
CN107043413A (zh) 一种肺结核相关的尿液生物标志蛋白及其应用
CN120948813A (zh) Ifi27蛋白作为用于甄别急性呼吸道病毒感染和非病毒感染的标志物的应用
EP2833148A1 (en) Method for determining severity of pneumococcal pneumonia
KR20160073699A (ko) 폐렴환자 소변에서 발굴된 폐렴연쇄상구균 진단용 바이오마커

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150601

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20150601

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20160316

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160323

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20160622

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160818

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20161027

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20161124

R150 Certificate of patent or registration of utility model

Ref document number: 6050337

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250